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ABSTRACT The interaction of the synthetic 21 amino acid peptide (AcE4K) with 1-oleoyl-2-[caproyl-7-NBD]-sn-glycero-3-
phosphocholine membranes is used as a model system for the pH-sensitive binding of fusion peptides to membranes. The
sequence of AcE4K (Ac-GLFEAIAGFIENGWEGMIDGK) is based on the sequence of the hemagglutinin HA2 fusion peptide
and has similar partitioning into phosphatidylcholine membranes as the viral peptide. pH-dependent partitioning in the
membrane, circular dichroism, tryptophan fluorescence, change of membrane area, and membrane strength, are measured
to characterize various key aspects of the peptide–membrane interaction. The experimental results show that the partitioning
of AcE4K in the membrane is pH dependent. The bound peptide inserts in the membrane, which increases the overall
membrane area in a pH-dependent manner, however the depth of insertion of the peptide in the membrane is independent
of pH. This result suggests that the binding of the peptide to the membrane is driven by the protonation of its three glutamatic
acids and the aspartic acid, which results in an increase of the number of bound molecules as the pH decreases from pH 7
to 4.5. The transition between the bound state and the free state is characterized by the Gibbs energy for peptide binding.
This Gibbs energy for pH 5 is equal to 30.2 kJ/mol (7.2 kcal/mol). Most of the change of the Gibbs energy during the
binding of AcE4K is due to the enthalpy of binding 27.3 kJ/mol (6.5 kcal/mol), while the entropy change is relatively small
and is on the order of 6.4 J/molK (2.3 cal/molK). The energy barrier separating the bound and the free state, is characterized
by the Gibbs energy of the transition state for peptide adsorption. This Gibbs energy is equal to 51.3 kJ/mol (12.3 kcal/mol).
The insertion of the peptide into the membrane is coupled with work for creation of a vacancy for the peptide in the
membrane. This work is calculated from the measured area occupied by a single peptide molecule (220 Å2) and the
membrane elasticity (190 mN/m), and is equal to 15.5 kJ/mol (3.7 kcal/mol). The comparison of the work for creating a
vacancy and the Gibbs energy of the transition state shows that the work for creating a vacancy may have significant effect
on the rate of peptide insertion and therefore plays an important role in peptide binding. Because the work for creating a
vacancy depends on membrane elasticity and the elasticity of the membrane is dependent on membrane composition, this
provides a tool for modulating the pH for membrane instability by changing membrane composition. The insertion of the
peptide in the membrane does not affect the membrane permeability for water, which shows that the peptide does not perturb
substantially the packing of the hydrocarbon region. However, the ability of the membrane to retain solutes in the presence
of peptide is compromised, suggesting that the inserted peptide promotes formation of short living pores. The integrity of the
membrane is substantially compromised below pH 4.8 (threshold pH), when large pores are formed and the membrane breaks
down. The binding of the peptide in the pore region is reversible, and the pore size varies on the experimental conditions,
which suggests that the peptide in the pore region does not form oligomers.
INTRODUCTION
Hemagglutinin (HA) plays a critical role in the entry of the
influenza virus in host cells (Stegmann and Helenius, 1993).
It mediates both the initial attachment of the virus to sialic
acid containing receptors on the host membrane (Rogers et
al., 1983) and the fusion between the viral membrane and
the endosomal membrane (Martin et al., 1981). The fusion
site contains at least three hemagglutinin homotrimers
(Bentz et al., 1990; Danieli et al., 1996). Each HA protein
from the homotrimers has two disulfide-linked subunits
HA1 and HA2, which at low pH undergo conformational
change and mediate fusion of the viral envelope and the host
cell membrane (Bentz et al., 1990; Bullough et al., 1994).
One of the subunits (HA1) contains the binding site for
sialic acid (Sauter et al., 1989), and the other (HA2) con-
tains a highly conserved apolar sequence of about 20 amino
acids at its N terminal (fusion peptide), which facilitates the
fusion event (Gething et al., 1986; Harter et al., 1989;
Durrer et al., 1996). The fusion of the viral membrane with
the cell membrane proceeds in several stages. In the first
stage, the conformational change of HA2 exposes the fusion
peptide about 100 Å from the viral membrane (Bullough et
al., 1994). In the second stage, the exposed fusion peptide
inserts in the closest membrane, which may be either the
host cell membrane or the viral membrane itself (Weber et
al., 1994). The insertion of the fusion peptide in the host
membrane provides the necessary link between the viral
envelope and the cell membrane. The third stage of the
fusion event is the creation and the expansion of the fusion
pore, which ultimately results in the mixing of the volume
contents of the virus and the cell (Bentz, 2000). Between the
second and the third stage there is an intermediate stage,
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which is very important for fusion, because it determines the
direction of the fusion event. In this stage, the viral mem-
brane and the host cell membrane are linked (Gaudin et al.,
1995) and reversible conducting pores are formed (Cherno-
mordic et al., 1998). However, the completion of the fusion
event depends on the restricted flow of lipid in the pore
region (Chernomordic et al., 1998). The transmembrane
domain of HA plays an important role in the regulation of
this process. The absence of this domain abolishes fusion
but not the hemifusion of the two bilayers (Kemble et al.,
1994; Melikyan et al., 1995). The role of the transmembrane
domain in fusion is rather physical because its substitution
with the transmembrane domain of other viral fusion pro-
teins (Schroth-Diez et al., 1998) recovers the fusion capa-
bility of HA. This suggests that the role of the transmem-
brane domain is probably limited to the creation of a
physical barrier for the diffusion of the membrane lipids in
the pore region (Bentz, 2000).
It is clear from the above mechanism of viral fusion that
the HA fusion peptide plays an essential role in the fusion
event. The removal of the peptide from the otherwise intact
HA results in abolishment of fusion (Ruigrok et al., 1988).
Furthermore, the mutations in this region affect the ability
of HA2 to fuse membranes, and the substitution of the
glycine at the peptide amino-terminal or its removal abol-
ishes fusion completely (Gething et al., 1986). Several stud-
ies have been done to reveal the ability of HA2 fusion
peptide mutants to insert into membranes (Lear and De-
Grado, 1987; Rafalski et al., 1991; Burger et al., 1991;
Longo et al., 1997, 1998), or to initiate content leakage
(Stegmann et al., 1985; Shangguan et al., 1996; Alford et
al., 1994). The ability of the mutants to insert into mem-
branes has been linked to their ability to form -helical
structures (Gray et al., 1996; Takahashi, 1990), however,
the ability to form these structures does not guarantee the
acquirement of fusogenic capabilities (Burger et al., 1991).
Spectroscopy measurements reveal that the folded peptides
resign close to the membrane interface, defined by the plane
separating the headgroup region and the hydrocarbon region
of the membrane lipids (Macosko et al., 1997; Zhou et al.,
2000). Also, these measurements show that the peptides
inserted at the membrane interface are oriented almost per-
pendicular to the normal to the membrane surface (Ishiguro,
et al., 1996; Zhou et al., 2000). In the continuing effort to
reveal the role of the fusion peptides in membrane fusion
and to evaluate their ability to trigger the release of encap-
sulated drugs in a pH-dependent manner, Bailey et al.
(1997) characterized the destabilization of model mem-
branes by a lipopetide derived from the influenza hemag-
glutinin. The lipopetide Lipo-AcE4K was made of the sol-
uble HA synthetic analog AcE4K studied in this work, and
the lipid distearoylglycerol. The peptide was anchored to
the lipid by its lysine side chain. Bailey et al. (1997), have
shown that the lipopetide is capable of anchoring to the
target membranes, promoting lipid mixing, and inducing
content leakage in a pH-dependent manner. However, the
anchored peptide cannot induce membrane fusion and ves-
icle-content mixing.
AcE4K studied in this work is similar to the soluble
peptide E4 studied by Rafalski et al. (1991), except for the
acylation of its N terminus and the presence of lysine at its
C terminus. E4 can also induce pH-dependent content leak-
age, however the soluble peptide cannot induce lipid mix-
ing. The inability of the anchored AcE4K peptide to induce
vesicle content mixing is consistent with the inability of the
GPI-anchored influenza hemagglutinin to induce content
mixing (Melikian et al., 1995). However, the comparison of
the blue shift of the tryptophan fluorescence and the forma-
tion of -helical structures upon the binding of the Lipo-
AcE4K to the membrane (Bailey et al. 1997) with the same
characteristics for the soluble E4 (Rafalski et al., 1991),
show that the two peptides behave differently. The blue shift
for the soluble peptide correlates very well with the forma-
tion of -helical structures (Rafalski et al. 1991), and both
characteristics depend on the solution pH. The blue shift of
the Lipo-AcE4K is dependent on pH, but the formation of
-helical structures is not (Bailey et al. 1997). This differ-
ence can arise from the anchoring of the peptide to the lipid
or can be a result of the different primary structure of
AcE4K and E4. To reveal the role of the anchoring of the
peptide to the lipid in the insertion of AcE4K we charac-
terize, in this work, the binding of AcE4K to 1-stearoyl-2-
oleoyl-sn-glycero-3-phosphocholine (SOPC) membranes.
We determined important thermodynamic characteristics of
this binding, such as the Gibbs energy and the enthalpy of
binding and the work for creating a vacancy in the mem-
brane, and we compared the experimentally measured char-
acteristics for AcE4K binding to the similar characteristics
for the binding of the distearoylglycerol-anchored AcE4K
studied by Bailey et al. (1997).
MATERIALS AND METHODS
Materials
The fusion peptide AcE4K with the sequence,
Ac-GLFEAIAGFIENGWEGMIDGK
was synthesized by INEX (Vancouver, Canada). SOPC, 1-oleoyl-2-[ca-
proyl-7-NBD]-sn-glycero-3-phosphocholine (OCPC(NBD-6)), 1-palmitoyl-
2-stearoyl(6-7)dibromo-sn-glycero-3-phosphocholine (PSPC(6-7)Br), and 1-
palmitoyl-2-stearoyl(9-10)dibromo-sn-glycero-3-phosphocholine (PSPC(9-
10)Br), were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL). L-
histidine was from (Sigma, St. Louis, MO).
Solution and Vesicle Preparation
Two types of vesicles were used in the experiments: giant vesicles
(20-m diameter), used in the micromanipulation experiments, and
100-nm extruded vesicles, used in the bulk experiments. The solutions used
for the different types of experiments were also different. The accuracy of
the measurements depended strongly on the ability to find buffers, which
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would not affect the measured parameters. For example, the vesicle pro-
jection length inside the holding pipet measured in the micromanipulation
experiments was very sensitive to the change of the solution composition.
The projection length changed when the solution used for vesicle prepa-
ration was replaced with the buffer solution used to dissolve the peptide.
The vesicles were formed in sucrose solution with low ionic strength,
whereas the peptide was dissolved in high ionic strength buffered solutions.
The buffered solutions could not be used for vesicle preparation because
the formed vesicles were very small in size and could not be used for
macromanipulation. Then the goal was to find a buffer solution where the
change of the vesicle projection length upon solution replacement was
small compared to the change of the projection length due to peptide
binding. One solution fulfilling this requirement was the solution made of
10 mM L-histidine (Sigma), 50 mM NaCl and 195 mM glucose, with final
osmolarity of 305 mOsm. This solution was used in the micropipette
experiments. The pH of the buffer was adjusted by adding HCl to decrease
its pH or by adding NaOH to increase its pH. After the addition of HCl or
NaOH, the osmolarity of the buffer increased. The osmolarity of the buffer
was adjusted back to 305 mOsm by adding water.
In the experiments of measuring the permeability of the membrane for
water (Olbrich et al., 2000), a single vesicle was transferred from buffer
with osmolarity 305 mOsm into buffer with osmolarity of 345 mOsm. The
osmolarity of the second buffer was increased by the addition of 40 mM
glucose (235 mM total amount of glucose in the solution). Because the
presence of histidine in this buffer affects circular dichroism (CD) mea-
surements, the buffers used in the spectroscopy measurements (CD and
fluorescence), were made by mixing different amounts of 0.1 M monobasic
sodium phosphate and 0.1 M dibasic sodium phosphate. The same buffers
were used in all other bulk experiments, such as the measurement of
peptide partitioning, and the titration calorimetry measurements.
The giant vesicles used in the micropipette experiments were made as
described elsewhere (Needham and Zhelev, 1996). Briefly, 30 microliters
of chloroform solution of 1 mg/ml lipid was spread onto a roughened
Teflon disk and the chloroform was evaporated under helium. Last traces
of solvent were removed by placing the disk in an evacuated desiccator for
2 h (Needham and Nunn, 1990). The so-formed dried lipid layers were
prehydrated with water vapor in a helium carrier gas and then fully
hydrated overnight in a sucrose solution at 40°C. The osmolarity of the
solution was 300 mOsm. The vesicles were resuspended in the experimen-
tal solution described above, which contained histidine, NaCl, and glucose.
The extruded vesicles were made either from SOPC or from PSPC(6-
7)Br, or PSPC(9-10)Br, depending on the experiment. Stock lipid solution
in chloroform (20 mg/ml lipid in chloroform) was dried on the wall of a
glass vial by using a stream of helium. The amount of lipid in the
preparations varied depending on the experiment. The dried lipid layers
were placed in vacuum for at least 24 h to remove the traces of chloroform.
The dried lipid was hydrated in the buffer used in the experiments. Lipid
hydration was coupled with freezing and thawing of the suspension three
times and vigorous vortexing. Finally, the hydrated lipid was extruded
seven times through 100-nm polycarbonate filters (Osmonics, Livermore,
CA) and used in the experiments.
Micromanipulation
The experimental chamber for the micromanipulation measurements was
3-mm thick and open at both sides, which allowed access to the interior of
the chamber. Experiments were performed at room temperature (23°C)
using an inverted Nikon microscope with 30 Hofmann modulation op-
tics. The microscope images were recorded using a COHU (San Diego,
CA) CCD camera, which was connected to a multiplexer (Model 401,
Vista Electronics, La Messa, CA). The micropipettes were made of 0.75
mm OD capillary glass tubing pulled to a fine point with a vertical pipette
puller (Model 730, David Kopf Instr., Tujunga, CA) and cut to the desired
diameter with a microforge. The pipettes were connected to a manometer
system that allowed the applied pressures to be changed and measured to
accuracy of 2 microatmospheres. Micropipette suction pressure was mea-
sured with differential transducer (Validyne DP15-24, Nortridge, CA). The
measured pressure, together with readings of real time, were multiplexed
on the recorded images. The recorded images were used to measure the
change of the vesicle projection length inside the holding pipette during
peptide adsorption and desorption, and during vesicle manipulation. The
measurements were done by using calibrated video calipers (Model 305,
Vista Electronics).
The experimental set-up for measuring peptide exchange with the
membrane was similar to the one used by Needham and Zhelev (1995) to
measure the exchange of lysolipids. The assay consists of a holding pipette
and two large pipettes. The holding pipette was used to hold a single
vesicle and the large pipettes were used to deliver solutions of different
composition to the vesicle surroundings. The holding pipette was incubated
for 15 min in solution containing 1 wt% bovine serum albumin (Sigma)
and then washed with the buffer used in the chamber. The incubation of the
holding pipette with albumin minimized the adhesion of the vesicle to the
pipette.
Initially, a single vesicle was chosen and held by the holding pipette.
The suction pressure in the holding pipette was set to 200 Pa. This pressure
was sufficient to keep the vesicle in the pipette while buffer was blown
from one of the large pipettes. The membrane tension induced by the
suction pressure was on the order of 0.2 mNm1, which was much smaller
than the critical tension for membrane breakdown on the order of 6 to 9
mNm1 (Needham and Nunn, 1990). After securing the vesicle with the
holding pipette, a buffer similar to the one in the experimental chamber was
flowed over the vesicle from one of the large pipettes (reference pipette).
This allowed the vesicle to establish a reference projection length in the
holding pipette during flow conditions. After a steady state was reached,
the reference pipette was replaced by the pipette containing peptide solu-
tion. The peptide solution was thereby blown over the vesicle and the
change of the projection length in the holding pipette was recorded.
When the vesicle was exposed to peptide solution for extended periods
of time, the membrane became saturated with peptide. This saturation was
observed by the arrest of the vesicle projection length inside the holding
pipette. At this point, the suction pressure of the holding pipette was
increased and then decreased several times to measure the change of the
vesicle projection length as function of the applied membrane tension.
Finally, the suction pressure in the holding pipette was increased until the
vesicle broke down. These measurements were used to give insight and to
make conclusions about the effect of peptide partitioning on membrane
integrity and elastic properties. The maximum tension  sustained by the
vesicle membrane (called critical membrane tension), was used as a mea-
sure for the strength of the membrane. This tension was calculated from the
law of Laplace applied to the spherical portion of the vesicle outside the
pipette and the spherical cap inside the pipette (Evans and Skalak, 1980),
P 2 1Rpip 1Rout , (1)
where P was the applied suction pressure, Rpip was the pipette radius and
Rout was the radius of the outside spherical portion of the vesicle.
The permeability of the membrane for water was determined by mea-
suring the volume change of a single vesicle when it was transferred from
low- to high-osmolarity solution. Initially, one of the large pipettes was
used to deliver reference solution. After establishing the initial reference
state, the solution with high osmolarity was delivered, and the change of
vesicle volume was measured. Both the reference solution and the high
osmolarity solution contained the same concentration of peptide and had
the same pH. The only difference between the two solutions was their
osmolarity. The volume change (dV/dt) of the vesicle after its exposure to
the high osmolarity solution was characterized by (Olbrich et al., 2000),
dV
dt LpAmRTc1 c2, (2)
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where Am was the membrane area, R was the gas constant, T was the
temperature, (c1  c2) was the solute concentration difference (which
determined the osmotic pressure difference), and the coefficient Lp was
defined by Pfvw/RT, where vw was the specific volume of water, and Pf was
the permeability coefficient.
The barrier energy for peptide dissociation was found from the mea-
sured rate of peptide desorption from giant vesicles at different tempera-
tures. The initial state in these measurements was a vesicle membrane
saturated with peptide. A vesicle membrane saturated with peptide was
obtained by flowing buffer with 10 M peptide over a single vesicle, until
steady state was reached. Then the vesicle was placed in a flow of
peptide-free buffer and the decrease of its projection length in the holding
pipette was measured. The dependence of the projection length change on
time was a single exponential (see Fig. 8 A), which suggested that only the
peptide that was previously intercalated in the outside monolayer was
desorbed. In this case, the number of peptide molecules Np, remaining in
the outside monolayer was given by (Zhelev, 1996),
Np Nipexp kmb1 Amkbmp   t , (3)
where Nip was the initial number of intercalated peptide molecules, kmb was
the rate of peptide transfer from the membrane to the buffer solution, Am
was the membrane area, kbm was the rate of peptide transfer from the bulk
to the membrane, p was the apparent mass transfer coefficient for the
stagnant layer, and t was the time. For the flow rates used in these
experiments, the mass transfer coefficient was large and the measured area
changes were not affected by the stagnant layer.
Bulk Measurements
Light scattering
Light scattering experiments were performed to test for peptide aggrega-
tion of concentrated peptide solutions at different pH. An N4 analyzer
(Coulter, Miami, FL) was used for these measurements. Peptide, 3.5 mg,
was dissolved in 1 ml of the buffer solution (pH 7.5). The pH of the sample
was lowered by adding HCl to the test cell.
Circular dicroism
CD was used to monitor the change of peptide secondary structure in the
absence and the presence of lipid for buffers of different pH. The CD
measurements were performed with Aviv 62DS spectropolarimeter. The
experiments were performed at 25°C using 1-mm-path-length quartz cu-
vette. The spectra were obtained from 190 to 260 nm with bandwidth 1 nm
and acquisition time 1 s. The scan speed was 20 nm/min, and each spectra
was average of 30 scans. Each measurement started by adding 200 l
phosphate buffer with the desired pH in the cuvette. The CD spectra of the
peptide-free buffer were measured to obtain baseline spectra. Then 10 l of
0.22 mM peptide solution was added to the buffer and its CD spectra were
measured. Finally, to the buffer-peptide solution was added 10 l vesicle
solution (100 nm extruded vesicles) with lipid concentration of 8 mM, and
the CD spectra were measured again. The corrected CD spectra for pure
peptide and peptide in presence of lipid were obtained by subtracting the
baseline for the peptide free buffer from the corresponding spectra.
Tryptophan fluorescence
The measurement of the blue shift and the quenching of the tryptophan
fluorescence were performed using spectrofluorimeter model RF-1501
(Shimadzu, Kyoto, Japan). A 0.25-mm quartz cuvette was used in the
measurements. All experiments were performed at 25°C. Extruded vesi-
cles, 100 nm, made of SOPC, PSPC(6-7)Br, PSPC(9-10)Br, and PSPC(11-
12)Br were used in the measurement of the quenching of the tryptophan
fluorescence. The stability of the lipids during the measurements was critical.
This stability was tested using NBD-lipids, for which the distance from the
fluorophore to the membrane interface was fixed. The membranes used in the
test experiments were made of SOPC:OCPC(NBD-6), OCPC(NBD-6):
PSPC(6-7)Br, OCPC(NBD-6):PSPC(9-10)Br, and OCPC(NBD-6):PSPC(11-
12)Br. In all membranes, the ratio of the NBD-lipid to the tested lipid was
(4.5:100). The data from the test measurements showed that SOPC, PSPC(6-
7)Br, and PSPC(9-10)Br were stable after multiple exposure to the excitation
light of the fluorimeter, but PSPC(11-12)Br was very unstable. Because of this
instability, the data with PSPC(11-12)Br membranes were not reported here.
Titration calorimetry
Titration calorimetry measurements were used to determine the enthalpy of
binding and the lipid-to-peptide ratio of binding. The measurements were
performed using high-sensitivity titration calorimeter (Microcal,
Northampton, MA). Initially the calorimeter chamber was filled with 2.5
ml buffer containing 10 M peptide. Extruded vesicles (100-nm diameter)
made in the same buffer were injected in the chamber in increments of 20
l (except for the first injection, which was 10 l). The increment of the
lipid concentration due to the vesicle injection was 21 mM lipid. The
reference chamber of the calorimeter was filled with water.
Light absorption
The light adsorption of tryptophan was used to determine peptide concentra-
tion in solutions free of lipid. The measurements were performed using Model
UV-1601 spectrophotometer (Shimadsu). The adsorption spectra of the tryp-
tophan for the window from 240 to 400 nm was used to determine peptide
concentration. The concentration was determined using the adsorption at 280
nm, and the adsorption spectra from 320 to 400 nm was used for establishing
baseline. Peptide concentration was measured for all stock peptide solutions as
well as for some of the filtered solutions from vesicle suspensions, when the
light scattering and the adsorption by the leaked lipid (lipid-related adsorption)
were either negligible or small relative to the peptide adsorption.
Peptide partitioning into membranes
The partitioning of the peptide in the vesicle membrane was measured
using a filtration kit (Micropartition Kit, Amicon Inc., Beverly, MA). For
the measurement of the partitioning coefficient, 100-nm extruded vesicles
were used and only half of the solution in the samples was passed through
the filter. The duration of filtration was between half an hour and one hour
depending on the vesicle concentration. The temperature of the experi-
ments was 25°C. Peptide partitioning was measured both for the buffer
used in the micropipette experiments and the phosphate buffer used in the
bulk experiments. The pH of the buffers was changed from pH 7.5 to pH
4.5. Three types of samples were made for each measurement: peptide
without lipid, lipid without peptide, and peptide and lipid. For the mea-
surement of partitioning for a given pH, there was one sample with peptide
without lipid and several samples with lipid without peptide and lipid with
peptide. The peptide concentration in all samples was 10 M, while the
lipid concentration was varied. The lipid concentration was varied until a
sample was found for which the bound peptide was from 30% to 70% of
the total peptide added. The filters used in this assay allowed some of the
lipid to pass, which affected the adsorption measurements. To eliminate the
dependence of the measured adsorption at 280 nm, on the “leaked” lipid,
the spectra of the filtered lipid with peptide sample was compared to the
spectra of filtered lipid without peptide sample. Several samples were
compared until a matching pair of spectra was found. Two spectra were
considered a matching pair when the adsorption for the short and the long
wavelengths was similar. To improve the ability to compare the spectra, the
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adsorption was measured in the range from 210 to 400 nm. The sample
with peptide and without lipid was used as a control for the loss of peptide
due to peptide binding to the tube wall and to the filter. We found that, for
the measured range of pH, the binding of AcE4K to the tube wall and the
filter was negligible. These measurements showed that the tubes and the
filters from the filtration kit could be used for the measurement of AcE4K
partitioning without preincubation with peptide solution.
Peptide binding (reversibility)
The reversibility of peptide binding was confirmed by washing the peptide
from a vesicle suspension that initially contained peptide (dilution exper-
iment). For this experiment, vesicles extruded through 200-nm polycar-
bonate filters were used. The experimental chamber was filled with 2 ml
solution containing 5 mg/ml lipid (as extruded vesicles) and 10 M
peptide. The pH of the solution was 5.5, which was the pH of the added
solution. Half of the solution from the lipid suspension containing peptide
was filtered through a 30-nm filter. The lost volume was recovered by
adding 1 ml peptide-free solution to the chamber. The vesicles and the
added solution were mixed and another 1 ml solution was filtered. The lost
volume was recovered again by adding 1 ml peptide-free solution and so
on. The filtered fractions were collected, and the fluorescence intensity of
the tryptophan at 350 nm was measured. In a separate experiment, the
fluorescent intensity of the tryptophan at 350 nm for peptide solutions with
range of concentrations from 0 to 10 M was measured. The determined
dependence of fluorescence intensity on tryptophan concentration was used
to determine the amount of peptide in the filtered fractions. The measure-
ment of the fluorescence intensity was the preferred method for determin-
ing peptide concentration in this case, because it was very difficult to
generate matching samples for the lipid leaked during the filtration.
RESULTS
AcE4K in the membrane and in the solution
We mentioned in the Introduction section that AcE4K was
very similar to the peptide E4 studied by Rafalski et al.
(1991), except that the N terminal of AcE4K was acylated
and it had a lysine at its C terminal. At pH 5, the insertion
of E4 in the membrane was coupled with a blue shift of the
fluorescence of its tryptophan (Rafalski et al. 1991). Simi-
larly, the fluorescence of the tryptophan of AcE4K was pH
dependent, and shifted to short wavelengths as the pH of the
solution decreased from pH 8 to 4.5 (Fig. 1). The blue shift
of the tryptophan fluorescence indicated that the trypto-
phan’s side chain was transferred from a hydrophilic envi-
ronment to a more hydrophobic environment (Lakowicz and
Keating, 1983). The measurement of the tryptophan fluo-
rescence for peptide solutions in the absence of lipid
showed that there was no blue shift (data not shown). This
result suggested that there was no measurable peptide ag-
gregation in the 10-M peptide solution for pH from 8 to
4.5. Similar behavior was observed by measuring the light
scattering of concentrated (1.4 mM) peptide solutions in the
absence of lipid (data not shown). The light scattering data
showed that there was no aggregation of peptide for pH
above 4.6. However, for pH below 4.6, there was significant
self-aggregation and precipitation of the peptide from the
solution. These data showed that there was a threshold pH
on the order of 4.5 (depending on peptide concentration),
above which the peptide in the solution did not form aggre-
gates. The peptide precipitated from the solution only in the
presence of lipid membranes when the pH was below 6. In
these conditions, the peptide adsorbed to the lipid mem-
branes, which was documented by the presence of the blue
shift.
The observation of the primary structure of AcE4K sug-
gested that it could form -helical structure and behave as
amphiphilic peptide. The measurement of the circular di-
FIGURE 1 Blue shift of the tryptophan fluo-
rescence verses the change of the buffer pH. The
peptide concentration was 10 M, and the lipid
concentration was 0.38 mM.
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chroism spectra of the Lipo-AcE4K by Bailey et al. (1997)
showed that, indeed, the lipid-anchored AcE4K formed
-helical structures. However, the measured -helical struc-
tures for the Lipo-AcE4K were independent of pH (Bailey
et al. 1997), and the tryptophan fluorescence had a blue shift
(Bailey et al. 1997). It was not clear from the measurements
of Bailey et al. (1997) whether the pH-independent -heli-
cal structures of the Lipo-AcE4K were a result of the
interaction of the anchored peptide with the membrane to
which the peptide was anchored, or it was a property of the
peptide itself. For each pH, we measured the CD spectra for
AcE4K in the absence and the presence of lipid (see Mate-
rials and Methods). These measurements showed that, in the
absence of lipid, AcE4K was in random coil conformation
regardless of the solution’s pH. In the presence of lipid
membranes, the measured CD spectra showed pH-depen-
dent formation of -helical structures (Fig. 2 A). These
measurements showed also that there were only two distinct
secondary structures: random coil (possibly from the pep-
tide in the solutions) and -helical (possibly from the pep-
tide bound to the membrane) (Fig. 2 A). The transition from
one conformation to the other occurred as the pH changed
from 8 to 4.5. For pH 4.5, the helicity of the peptide was
close to the 100% theoretical helicity calculated from the
model used by Chang et al. (1978). Then the helicity mea-
sured for pH 4.5 was considered a good estimate for the
maximum helicity of AcE4K. The change of helicity was
characterized by the change of the measured ellipticity at
222 nm (Fig. 2 B). The comparison of Fig. 2 B and Fig. 1
showed that the change of peptide helicity correlated very
well with the tryptophan blue shift. Therefore, both the blue
shift and the increase of peptide helicity indicated that
AcE4K had a tendency to bind to the membrane when the
pH decreased from 6 to 4.5.
The folded AcE4K was expected to be amphiphilic and
most likely partitioned at the membrane interface. The ob-
servation of the helical wheel of AcE4K (not shown) sug-
gested that the side chain of the triptophan should be close
to the membrane interface. The anticipated position of
AcE4K in the membrane was similar to the position of the
wild-type HA2 fusion peptide. The wild-type peptide re-
signed at the membrane interface and was almost perpen-
dicular to the normal of the membrane surface (Zhou et al.,
2000). To confirm this assumption, we measured the depth
of insertion of the tryptophan side chain in the membrane
and compared it with the depth of insertion of the trypto-
phan of the wild-type HA2. We used the paralax method
developed by Chattopadhyay and London (1987) for the
measurement of the depth of insertion of the tryptophan side
chain.
The paralax method used the quenching of the trypto-
phan’s fluorescence by dibromo lipids. The method re-
quired almost all of the peptide molecules to be bound to the
membrane. The binding of the peptide was monitored by
measuring the blue shift of preparations containing the same
amount of peptide (10 M), and increasing the amount of
lipid. The maximum blue shift for solution with pH 5, was
measured for lipid concentrations on the order of 3 mM (not
shown). To ensure maximum binding, the measurements of
tryptophan quenching were performed using samples con-
taining 10 M peptide and 5.5 mM lipid. The maximum
quenching was measured for the membranes made of
PSPC(6-7)Br, and the minimum quenching was measured
for the pure SOPC membranes (no bromo-substitution were
present) (Fig. 3). The maximum quenching for the mem-
brane made of PSPC(6-7)Br suggested that the tryptophan
side chain was closer to the sixth and the seventh carbon in
the lipid acyl chain than to the ninth and the tenth carbon.
The distance zF1 of the tryptophan from the shallower
quencher (PSPC(6-7)Br) was determined by (Chatto-
padhyay and London, 1987)
zF1	L122  1/ClnF1/F22L12  , (4)
where L12 was the distance between the two quenchers, C
was the quencher concentration per unit membrane area (in
this case, the area occupied by the two quenchers was equal
to the area of one lipid molecule), the ratio F1/F2 was the
ratio of the intensity of the tryptophan fluorescence from the
membrane containing the shallower quencher to the trypto-
phan fluorescence from the membrane containing the
deeper quencher. The distance zF1 was positive when the
tryptophan was between the two quenchers and negative
when the tryptophan was closer to the membrane interface
than to the shallower quencher.
The distance between the shallower quencher and the
tryptophan was calculated using the following parameters.
The area of one PC molecule was assumed equal to 65 Å2
(McIntosh and Simon, 1986). This corresponded to
quencher concentration on the order of 0.031 (1/Å). The
ratio F1/F2 was 0.28, and the distance between the quench-
ers was 3.75 Å. Then the calculated distance zF1 was 0.1 Å.
Therefore, the tryptophan side chain was almost at the same
depth as the shallower quencher. The distance of the shal-
lower quencher to the membrane interface (which was con-
sidered to be close to the carbonyl groups), was on the order
of 8 Å. Then the tryptophan side chain was 8 Å from the
membrane interface. This was in good agreement with the
distance from the tryptophan back-bone to the lipid phos-
phate group on the order of 5 Å measured with EPR (Zhou
et al., 2000), which placed the tryptophan side chain 5 Å
from the membrane interface.
Tryptophan quenching was also measured for pH 6 using
the same procedure as the one already described for pH 5.
The ratio F1/F2 for the solution with pH 6, was equal to
0.28, which was equal to the same ratio for pH 5. This result
showed that the depth of insertion of AcE4K in the mem-
brane was independent of pH. This observation was in
agreement with the data of Luneberg et al. (1995) and Zhou
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FIGURE 2 (A) CD spectra for AcE4K for lipid containing solutions with different pH. The peptide concentration was 10 M, and the lipid concentration
was 0.36 mM. The solid curve represents the calculated spectra for 100% ellipticity (see text). In the absence of lipid, the peptide remained in random coil
conformation for the range of pH studied. In this case, the measured CD spectra (not shown) were almost identical to the CD spectra measured for lipid
containing solutions at pH 8. (B) Change of AcE4K ellipticity at 222 nm verses pH.
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et al., (2000), who also showed that the depth of insertion of
the wild-type HA2 fusion peptide was independent of pH.
Thermodynamics of AcE4K binding
The data presented so far suggested that the binding of
AcE4K to the membrane was coupled with a conforma-
tional change from random coil to -helical and with the
insertion of the folded peptide at the membrane interface.
The transfer of the peptide from the solution to the mem-
brane interface depended on several energy characteristics,
such as the change of the Gibbs energy, the change of the
enthalpy and the entropy of the peptide–membrane com-
plex, and the barrier energy for peptide transfer to and from
the membrane. We used a simple thermodynamic model for
characterizing peptide binding, where the bound state and
the free (unbound) state of the peptide were separated by a
single energy barrier.
The measurement of peptide partitioning (Fig. 4 A) with
the filtration method (see Materials and Methods) showed
that the amount of bound peptide increased relative to the
free peptide, when the pH of the solution decreased from pH
7.5 to 4.5. We assumed that, for pH below 5.5, all peptide
in the solution was available for binding. Then, for any
given amount of lipid, the ratio of the concentration of the
free peptide to the initial peptide concentration (total pep-
tide), depended on the partition coefficient and the lipid
concentration. The ratio of the free peptide to the total
peptide was
free peptide
total peptide
1
1 Kp
L
, (5)
where [L] was the amount of lipid (mol) divided by 55.56,
which accounted for the cratic contribution to the binding
equilibrium, and Kp was the partition coefficient.
The binding of the peptide to the membrane could also be
viewed as a two-step process, where the peptide molecules
were initially protonated and then the protonated species
could bind to the membrane. In this scenario, not all peptide
molecules would be available for binding, and the ratio of
the free peptide to the total peptide would deviate from the
dependence predicted by Eq. 5. When the protonation is
coupled with the binding of the peptide to the membrane,
Eq. 5 would hold. (The coupling between the binding of the
peptide to the membrane and its protonation is sometime
referred to as an apparent increase of the pH for protonation
in the presence of membranes.) The data in Fig. 4 B showed
that the measured ratio of the free peptide to the total
peptide was represented adequately by Eq. 5. The good
agreement between the experimental data and the curve
calculated from Eq. 5 suggested that all peptide molecules
in the solution were available for binding. In this case, the
partition coefficient Kp was equal to the equilibrium con-
FIGURE 3 Fluorescence intensity of tryptophan
from AcE4K inserted in SOPC membranes and mem-
branes made of di-bromo lipids. The peptide concen-
tration was 10 M, and the pH was 5.
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stant K. Therefore, we used the measured partition coeffi-
cients for the calculation of the Gibbs energy G0 for
peptide transfer from the solution to the membrane,
G0RT ln Kp, (6)
where R was the gas constant and T was the temperature.
The measured partition coefficient for pH 5.5 (Fig. 4 A)
was on the order of 4.8  104. The standard Gibbs energy
corresponding to this partition coefficient was 26.7 kJ/
mol (6.4 kcal/mol). The partition coefficient for pH 5 was
on the order of 2  105, and the corresponding Gibbs
energy was 30.2 kJ/mol (7.2 kcal/mol). The partition
coefficients and the corresponding Gibbs energies could
also be calculated from the blue shift data in Fig. 1, and the
ellipticity data for 222 nm from Fig. 2. The CD spectra in
Fig. 2 showed that the helicity for pH 4.5 was almost 100%,
thus suggesting that almost all peptide was bound to the
membrane. The solution contained 0.36 mM lipid and at pH
8, almost all peptide was free. Then the ratio of the bound
verses free peptide for pH 5, calculated from the measured
FIGURE 4 (A) Partition coefficient for SOPC mem-
branes determined with the filtration method. The circles
represent the data points for vesicles in phosphate buffer,
and the squares are the data points for vesicles in the
buffer used in the micropipette experiments (see Ma-
terials and Methods). The partition coefficient for pH
4.5, which is not shown in the graph, was 1  106. (B)
Ratio of the bound peptide to the total peptide verses
the lipid concentration, and the prediction of the
model, assuming that all peptide in the solution was
available for binding. The peptide concentration was
10 M, and the pH was 5.5.
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ellipticities at pH 4.5, 5, and 8, was on the order of 1.3. The
partition coefficient corresponding to this ratio was 2 105.
Similarly, the lipid concentration in the blue shift experi-
ments (Fig. 1), was 0.38 mM, and the ratio of the bound to
the free peptide at pH 5 was 1.4. The partition coefficient
corresponding to this ratio was 2  105. The partition
coefficients determined from the three types of measure-
ment, filtration, CD, and tryptophan fluorescence, were very
similar. This similarity suggested that both the measured
blue shift and the measured change of peptide helicity were
directly related to the increased amount of bound AcE4K to
the membrane when the pH decreased.
The enthalpy of binding of AcE4K to the SOPC mem-
branes was measured using titration calorimetry. In these
experiments, concentrated lipid solution (42 mM maximum
concentration), as 100-nm extruded vesicles, was injected
into a solution containing 10 M peptide (Seelig, 1997).
After the injection, the vesicles started to mix with the
solution in the chamber, and the peptide started to bind to
the vesicle membranes. The heat transfer during this process
was measured. Similar measurements were performed for
the injection of lipid vesicles in a chamber containing pep-
tide-free buffer. The difference between the measured heat
transfer in the two cases was used to determine the enthalpy
of peptide binding (Fig. 5). The fitting of the experimental
data showed that the enthalpy of AcE4K binding was on the
order of H0  27.3 kJ/mol (6.5 kcal/mol), and the
lipid-to-peptide ratio was 180 lipids per peptide. The bind-
ing constant was not determined from the titration calorim-
etry data because of uncertainties in their interpretation
(Seelig, 1997). The titration calorimetry measurements were
performed at pH 5. The comparison of the Gibbs energy for
pH 5 and the enthalpy of binding allowed the calculation of
the entropy change S0 during binding. The entropy change
was determined from G0  H0  TS0, and was equal
to S0  6.4 J/mol.K (2.3 cal/mol.K). Finally, the heat
released during peptide binding was positive, suggesting
that AcE4K binding was exothermic.
Exchange of ACE4K with SOPC membranes
The data presented so far provided equilibrium characteris-
tics for the binding of AcE4K to the membrane. We used the
micropipette assay developed in our laboratory (Needahm
and Zhelev, 1995) to study the kinetics of exchange of the
peptide with the membrane. In this assay, a single vesicle
was held by a pipette and solutions of different composition
were delivered in the surroundings of the vesicle using two
large micropipettes. After the exposure of the vesicle to 10
M AcE4K solution at pH 5.5, the vesicle projection length
inside the holding pipette increased. This increase of the
vesicle projection length could be either a result of the
increase of the vesicle area due to the insertion of the
peptide molecules in the membrane, or the decrease of the
vesicle volume due to the formation of pores and loss of
solute. The contribution of the change of the vesicle area to
the change of the projection length was determined from the
comparison of the data from two series of measurements. In
the first series, a single vesicle was exposed to peptide
solution for 21 min (1260 s) by flowing peptide solution
from a large pipette (Fig. 6, open circles). The peptide from
FIGURE 5 AcE4K binding measured with titration
calorimetry. The peptide concentration was 10 M, the
pH was 5, and the temperature was 25°C. 100-nm ex-
truded vesicles were injected in the peptide solution.
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the solution was adsorbed to the vesicle membrane and the
projection length in the holding pipette increased. Then the
vesicle was exposed to peptide-free solution and the peptide
desorbed, which was coupled with a decrease of the vesicle
projection length (Fig. 6). In the second series of measure-
ments, a single vesicle was exposed to peptide solution for
7 min (420 s) and then the peptide was desorbed using the
same assay as in the first series. The exposure of the vesicle
to peptide solution and the peptide desorption were repeated
two times, which provided the same total time of exposure
to the peptide solution (21 min), as in the first series. The
vesicles used in these measurements had similar sizes and
the used holding pipettes had similar radii, which provided
similar changes of the vesicle projection length for similar
area and volume changes. The comparison of the data from
the two series of measurements (Fig. 6), showed that the
increase of the vesicle projection length during peptide
adsorption was larger for longer exposure to peptide solu-
tion. In contrast, the change of the projection length during
peptide desorption was similar in all cases. These data could
be explained either by assuming that only part of the ad-
sorbed peptide could be desorbed (partial desorption), or
that the insertion of the peptide in the vesicle membrane
induced content leakage and therefore volume change. In
this case, the change of the projection length during peptide
desorption was coupled with the change of membrane area
due to the decrease of the membrane area occupied by the
inserted peptide.
Partial desorption would take place only when two pep-
tide species were present, one with low affinity of binding
to the membrane and another with high affinity of binding.
The mass spectrometry and HPLC measurements showed
that there was only one species in the peptide samples.
Nevertheless, we tested the possibility of the presence of
nondesorbing species by performing the dilution experiment
described in the Materials and Methods section (Fig. 7).
From the data of this experiment, it was clear that the total
amount of washed peptide (after correcting for the dilution
of the peptide in the filtered fractions), was almost equal to
the amount of peptide added to the experimental chamber.
(The initial peptide concentration was 10 M, and the
apparent concentration of the washed peptide calculated
from the concentrations of the fractions in Fig. 7 was 12
M.) The similarity of the amount of washed peptide and
the initial amount of the added peptide, showed that almost
all peptide was desorbed. Therefore, the residual increase of
the vesicle projection length in the micropipette after
AcE4K desorption (Fig. 6) was a result of vesicle volume
change. The comparison of the data from the two sets of
measurements in Fig. 6 showed also that the residual in-
crease of the vesicle projection length was almost linearly
dependent on the time of incubation with the peptide solu-
tion. It seems then, that the presence of peptide inserted in
the vesicle membrane did, in fact, induce leakage of vesicle
content resulting in a decrease of the vesicle volume (the
vesicle was held under low but significant suction pressure
and so any reduction in the permeability of the membrane to
the encapsulated solute could cause vesicle deflation).
During peptide desorption, the highest amount of peptide
was present in the membrane in the initial state, just before
transferring the vesicle to peptide-free solution. As the
peptide started to desorb, its amount in the membrane de-
creased. Therefore, during peptide desorption, the overall
exposure of the membrane to the inserted peptide was
relatively small compared to the membrane exposure during
peptide adsorption. Also, the time of desorption was very
short, on the order of 5–15 s (Fig. 8 A), whereas the time for
reaching a steady state during peptide adsorption was longer
than 5 min. Thus, the measured change of the vesicle
projection length during peptide desorption was considered
to represent the change of the vesicle area only. The mea-
sured relative change of the vesicle area during peptide
desorption at pH 5.5 was on the order of 6%.
Another characteristic of the binding of AcE4K to the
membrane was the energy barrier, which separated the
bound state and the unbound state of the peptide. This
barrier was characterized by the Gibbs energies of the
transition state. There were two Gibbs energies of transition
state, one for the transition from free state to the transition
state (Gibbs energy of adsorption Ga), and another for
FIGURE 6 Peptide adsorption and desorbtion at pH 5.4. A single vesicle
was exposed continuously to peptide buffer for 21 min (closed circles) and
then the peptide was washed (open circles) with peptide-free buffer at the
same pH. Another vesicle of similar size was exposed to peptide buffer
(closed diamonds) and then washed (open diamonds) three times with
peptide-free buffer. The total time of exposure of the two vesicles to
peptide solution was the same. The projection length change after every
washing of the adsorbed peptide was similar, and the final residual increase
of the vesicle projection length was similar for the two vesicles. The
change of the projection length during peptide desorption corresponded to
6% change of the vesicle area.
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the transition from bound state to the transition state (Gibbs
energy of desorption Gd). The difference of the two
transition Gibbs energies was equal to the Gibbs energy
G0 for peptide transfer from the solution to the membrane.
The Gibbs energy of AcE4K desorption was calculated
from the measured rate of peptide desorption for different
temperatures (Fig. 8 A) and the corresponding barrier en-
ergy of desorption Ed. The rate of peptide desorption k and
the barrier energy Ed were related by the Arrhenius equa-
tion,
ln k ln X
Ed
RT , (7)
where X was a constant independent of temperature. The
barrier energy was found from the slope of the dependence
of the rate of peptide desorption on the reciprocal of the
temperature. The Gibbs energy of the transition state Gd
was calculated from the barrier energy using
Gd Hd TSd,
Hd Ed RT,
Sd RlnX0hNART   1 , (8)
where Hd and Sd were the enthalpy and the entropy
of the transition state, T was the temperature, Ed was the
barrier energy for desorption, R was the gas constant, X0
was the intercept from the Arrhenius plot in Fig. 8 B, h was
the Plank’s constant, and NA was the Avogadro’s number.
The data in Fig. 8 A, showed that the measured kinetics of
the change of the relative projection length (which was
related to the relative area change), during peptide desorp-
tion was a single exponential. The rate of desorption was
chosen equal to the exponential factor of this dependence.
The dependence of the rate of peptide desorption on the
reciprocal of the temperature shown in Fig. 8 B, allowed to
determine the barrier energy for desorption. This energy
was equal to 47.5 kJ/mol (11.3 kcal/mol). The coeffi-
cient X was determined from the intercept in Fig. 8 B, and
was 5  1010 (1/s). Then the Gibbs energy of peptide
desorption was 78.5 kJ/mol (18.8 kcal/mol).
The measurement of the partitioning of AcE4K in the
SOPC membrane showed that the partitioning of the peptide
was pH dependent. Therefore, if peptide partitioning was
coupled with actual peptide insertion, we expected to ob-
serve larger area changes for the same bulk concentration of
the peptide when the pH of the solution was decreased from
pH 7 to 4.5. Indeed, the data in Fig. 9 showed that the
steady-state projection lengths increased with the decrease
of the solution’s pH. The increase of the projection length
with the decrease of the pH provided a direct indication that
the adsorbed peptide was inserted in the membrane. In these
measurements, the vesicles were stable for solutions having
pH above 4.8 (in these conditions, the vesicles remained
stable for more than half an hour). However, for pH below
4.8, the vesicles were very unstable and broke during the
initial adsorption of the peptide (Fig. 9). This behavior was
different from the equilibrium bulk measurements, where
the measured characteristics (peptide partitioning, trypto-
FIGURE 7 Peptide concentration of the sample frac-
tions in the dilution experiment. The dilution for each
fraction was 1:1. The peptide concentration in every
following fraction was half of the concentration in the
previous fraction. The initial peptide concentration in
the sample was 10 M, and the pH was 5.
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phan blue shift, and Ac4K helicity) changed continuously
with the decrease of the pH down to pH 4.5.
Effect of AcE4K binding on the properties of
SOPC membranes
The intercalation of AcE4K in the membrane clearly
changed membrane composition. This change of membrane
composition could result in change of the membrane prop-
erties, such as the strength of the membrane, its permeabil-
ity for water, and its area expansion modulus. The strength
of the membrane was characterized by the tension for mem-
brane failure (critical membrane tensions). For SOPC ves-
icles in glucose, the critical membrane tension was 10.5 	
1 mN/m. The critical membrane tension in peptide-free
buffer at pH 5 was 9.5	 1 mN/m, and, for buffer containing
10 M peptide, at pH 5 it was 5.8	 1.1 mN/m. The critical
membrane tension was measured also immediately after
peptide desorption and it was 5.3 	 2 mN/m. These mea-
surements showed that the presence of the intercalated
peptide decreased the membrane strength. However, this
decrease was similar to the decrease of the membrane
strength when the vesicles were transferred from glucose
solution to peptide-free buffer. The similarity of the mem-
brane strength after peptide desorption to the membrane
strength in the presence of peptide suggested that, immedi-
ately after desorption, there were still traces of peptide
present in the membrane.
The resistance of the membrane for area dilation was
characterized by the area expansion modulus (Kwok and
FIGURE 8 (A) Kinetics of peptide desorption at
different temperature characterized by the change of
the vesicle projection length measured with the mi-
cropipette assay during peptide washing. (B) Loga-
rithm of the rate of peptide desorption verses the
inverse temperature. The measurements were per-
formed at pH 5.5.
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Evans 1981; Needham and Nunn, 1990; Needham and
Zhelev, 1996). The area expansion modulus could not be
measured in the presence of inserted peptide because the
volume of the vesicles changed continuously. The continu-
ous change of the vesicle volume made it impossible to
distinguish between the change of the vesicle projection
length due to the volume change and due to the applied
tension. The area expansion modulus was measured for the
same vesicle before and after desorption (not shown). This
measurement showed that the area expansion modulus after
peptide desorption was equal to the area expansion modulus
before peptide adsorption. This finding confirmed the con-
clusion made earlier that AcE4K desorbs almost completely
after the transfer of the vesicles in peptide-free buffer.
We measured the permeability of the membrane for water
both in the absence and presence of inserted peptide. The
permeability of the membrane for water was sensitive to the
ordering of the membrane lipids close to the membrane
interface (Olbricht et al., 2000). This sensitivity was attrib-
uted to the presence of free volume in the hydrocarbon
region close to the membrane interface (Marrink and
Brensen, 1994; Marrink and Berkowitz, 1995). The mea-
surement of the permeability for water of SOPC membranes
with and without adsorbed peptide showed that the mem-
brane permeability for water was independent of the pres-
ence of intercalated peptide (not shown). This result sug-
gested that the insertion of AcE4K in the membrane did not
perturb significantly the packing of the hydrocarbon region
close to the membrane interface. This was another confir-
mation to the conclusion from the parallax measurements
that AcE4K did not insert deep into the hydrocarbon region.
Effect of peptide insertion on membrane stability
below pH 4.8
The breakdown of the vesicle membrane in the coarse of
peptide adsorption for pH below 4.8 (Fig. 9) showed that
either the membrane stability was compromised or the ad-
sorbing peptide acquired a capability to disturb significantly
the structure of the membrane. The measurement of mem-
brane strength for the range of pH from 5.5 to 4.5 showed
that the strength of the membrane was not affected by the
decrease of pH (not shown). Therefore, the reduced mem-
brane stability below pH 4.8 was attributed to the insertion
of the peptide in the membrane. The threshold pH for
membrane instability was very close to the measured pH on
the order of 4.6 for the aggregation of AcE4K in concen-
trated peptide solutions. Also, the threshold pH was close to
the pK of 4.7 for the three glutamatic acids and the aspartic
acid of AcE4K. Therefore, there was a possibility that
membrane breakdown was a result of membrane defects
initiated by peptide aggregates. If such aggregates were
present, their concentration was small compared to the
concentration of the single peptide molecules, because be-
low pH 4.8 we did not observe either tryptophan blue shift
or the formation of -helical structures in the absence of
lipid. Two possibilities were considered: aggregate forma-
tion by the already adsorbed peptide, and aggregate forma-
tion in the solution before adsorption and fusion of peptide
aggregates with the membrane. To distinguish between
these two possibilities, we tried to protect the vesicle mem-
brane against adsorption of peptide aggregates by using
grafted poly(ethylene glycol) (PEG). We had shown (Need-
ham et al., 1997) that the grafted PEG reduced the rate of
micelle fusion with the membrane during the exchange of
lysolipid with SOPC membranes. We wanted to use grafted
PEG to prevent the peptide aggregates from reaching the
membrane surface and inducing membrane breakdown.
However, the use of grafted PEG at concentrations that
almost completely inhibited micelle fusion (Needham et al.,
1997) were not sufficient to reduce the destabilizing effect
of the adsorbing AcE4K. (The vesicles with grafted PEG
broke similarly to the vesicles without grafted PEG.) This
lack of protection by the grafted PEG was either due to
polymer precipitation at low pH or loss of protection due to
the different nature of the interaction of the grafter polymer
and the peptide aggregates, compared to the grafted PEG–
micelle interactions.
Another possibility for the lack of protection by the
grafted PEG was the possible aggregation of the already
adsorbed peptide in the membrane. We tested this possibil-
ity by initially adsorbing AcE4K to the membrane at pH 5.5,
and then exposing the membrane with the adsorbed peptide
to peptide-free buffer at pH 4.7. The result from this test
FIGURE 9 The exposure of single giant SOPC vesicles to peptide so-
lutions resulted in an increase of the vesicle projection length inside the
holding pipette. The magnitude of the projection length increase was
dependent on pH and increased with the decrease of the pH. For pH 4.75,
the vesicle broke down during adsorption. The peptide concentration was
10 M.
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was that the peptide desorbed, similar to the peptide desorp-
tion at pH 5.5. Thus, either the rate of peptide desorption
was faster than the rate of aggregation, or the aggregation of
the peptide in the membrane was not the factor determining
membrane instability. We continued to explore these pos-
sibilities by initially adsorbing peptide at pH 5.4 and then
transferring the vesicle with the adsorbed peptide to a so-
lution with pH 4.7, which contained the same amount of
peptide as the initial solution (Fig. 10). In these experi-
ments, we measured the change of the vesicle projection
length in the holding pipette and the lifetime of the vesicle
after exposure to the peptide solution at pH 4.7. The mea-
surements were compared to the same measurements when
a single vesicle was exposed directly to peptide solution at
pH 4.7 (Fig. 10). The experimental data showed that the
presence of already adsorbed peptide increased the lifetime
of the vesicles in the peptide solution with pH 4.7. The
membrane lifetime in the presence of pre-adsorbed peptide
was 220.2 	 26.9 s, and that for direct exposure to peptide
solution with pH 4.7 was 85.8 	 7.6 s. Another important
difference between the two sets of measurements was that
the vesicles exposed directly to peptide solution at pH 4.7
broke instantaneously, whereas the vesicles with already
adsorbed peptide swelled. The swelling of the vesicles sug-
gested that there were stable and solute-selective pores with
average size on the order of 5 nm, which were able to
transport selectively glucose and small ions from the sur-
rounding buffer, but not sucrose, from the vesicle interior.
As a result, the sucrose-loaded vesicles swelled until break-
ing down (Fig. 10). These measurements showed that mem-
brane instability was not caused by the aggregation of the
adsorbed peptide molecules in the membrane, but rather was
initiated by species formed in the bulk. We speculate that
these species are peptide aggregates formed in the solution,
because peptide monomers exchanged with the membrane
at pH 4.7 in a similar way as they did at pH 5.5.
The final set of measurements was designed to test the
reversibility of the peptide-induced pore formation. In these
measurements, stable selective pores were formed in the
membrane of a single vesicle. The pores caused the vesicle
to swell. In the course of swelling, the vesicle was exposed
to peptide-free solution with the same pH (Fig. 11). Almost
immediately after the exposure of the vesicle to the peptide-
free solution the swelling stopped and the adsorbed peptide
started to desorb. This result showed that the binding of the
peptide in the pore region was reversible.
DISCUSSION
The binding of the AcE4K peptide to SOPC membranes
studied in this work was coupled with an increase of the
membrane area. The increase of membrane area showed that
AcE4K was inserted in the membrane interior. This behav-
ior was consistent with the increase of the surface pressure
of lipid monolayers upon the binding of the similar peptide
E4 (Rafalski et al., 1991). Similar coupling between peptide
binding and membrane area increase was measured also for
the wild-type w-20 peptide from the X31 influenza virus
(Longo et al., 1997, 1998). The binding of E4 to the mem-
brane was similar to the binding of w-20 and the primary
amino sequence of the two peptides was identical except for
one amino acid (E4 had at fourth position a glutamatic acid,
whereas w-20 had a glycine, Rafalski et al. 1991). AcE4K
was similar to E4, except that its N terminal was acetylated
and it had lysine at its C terminal. Therefore, the binding of
AcE4K to the SOPC membrane was compared to the similar
binding of E4 and w-20. The importance of the N terminal
for the binding of HA2 was demonstrated by Gething et al.
(1986) and others (Burger et al., 1991; Steinhauer et al.,
1995; Gray et al., 1996). They showed that the removal of
the glycine at the N terminal completely abolishes the
binding of w-20 to the membrane and the formation of
-helical structures by the peptide. In contrast, the acylation
of the N terminal enhanced the formation of -helical
structures in nonpolar solvents (Rohl et al., 1996). There-
fore, the acylation of the N terminal of AcE4K was not
expected to affect adversely its ability to bind to the SOPC
membrane. The presence of the lysine at the C-terminal of
AcE4K increased the overall positive charge of the peptide.
FIGURE 10 Change of the vesicle projection length after direct expo-
sure to peptide solution with pH 4.7 (triangles), initial exposure to peptide
solution with pH 5.5 (open circles), and then exposure to peptide solution
with pH 4.7 (closed circles). The direct exposure of the vesicle to peptide
solution at pH 4.7 resulted in vesicle breakdown during adsorption. The
exposure of the vesicle to peptide solution with pH 5.5 led to increase of
the projection length. The subsequent exposure to peptide solution at pH
4.7 resulted in additional increase of the projection length and then fast
decrease of the projection length. The increase of the projection length
could be a result of additional area change or volume loss. The fast
decrease of the projection length was a result of pore formation and vesicle
swelling. The peptide concentration was 10 M.
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However, this was not expected to affect significantly the
binding of the peptide, because EPR measurement of the
position of w-20 in the membrane (Zhou et al., 2000)
suggested that the side chain of the lysine at the C terminal
would partition in the lipid headgroup region of the mem-
brane. The parallax measurements showed that the trypto-
phan side chain of AcE4K inserted to the same depth as the
same side chain of w-20, confirming that the presence of the
lysine at the C terminal did not affect adversely the insertion
of the peptide.
The insertion of AcE4K in the membrane increased the
membrane area. In a microscopic scale, this peptide inser-
tion required rearrangement of the lipid molecules in one of
the membrane monolayers and the formation of a vacancy
for the peptide. The overall free energy change accompa-
nying this process had two major components, one related to
the change of the free energy of the peptide during its
transition from the water solution to the membrane inter-
face, and the other related to the change of the free energy
of the membrane. We consider the work for creating a
vacancy to be related to the change of the free energy of the
membrane.
Due to the difference of the accessibility of the inside and
the outside membrane monolayers, the inserted peptide ini-
tially partitions in the outside membrane monolayer. The
asymmetry of the initial peptide distribution between the
two membrane monolayers creates intermonolayer stress,
which is coupled with change of the membrane free energy.
This stress is eventually relaxed as either peptide molecules
or lipids or both are transferred across the membrane. An-
other source of change of the membrane free energy arises
from the difference of the packing conditions of the lipids
bordering the inserted peptide molecules, and the lipids
away from the sites of insertion. The change of lipid pack-
ing is characterized using mean-field membrane elasticity
(Dan and Safran, 1995; Nielsen et al., 1998). In this case,
the change of the membrane free energy is independent of
time and represents the equilibrium change of the mem-
brane free energy due to molecular insertion. The equilib-
rium free energy has been modeled extensively (May, 2000)
because of its importance for channel activity (Lundbaek et
al., 1997; Lundbaek and Andersen, 1999; Lewis and Cafiso,
1999).
The exchange of AcE4K with SOPC vesicles held by
micropipettes presented in this work is characterized by
both the equilibrium and the nonequilibrium change of the
membrane free energy. The modeling of the equilibrium
change of the membrane free energy is done successfully
for symmetrical vacancies, such as the inclusion vacancy for
the gramicidin channel (May, 2000). The overall predictions
of the models is that the magnitude of the increase of the
free energy depends almost linearly on the mismatch be-
tween the membrane thickness and the apparent hydropho-
bic thickness of the inserted molecule (Lundbaek and
Anderson, 1999). The exact geometry of the vacancy of
AcE4K (or the wild-type wt-20 peptide) is unknown. How-
FIGURE 11 Reversible pores stimulated by
AcE4K. The formation of pores was stimulated by
exposing a single vesicle to peptide solution with
reduced peptide concentration and with pH 4.7. After
pore formation, the vesicle started to swell, and its
projection length in the holding pipette started to
decrease. During swelling, the vesicle was exposed to
peptide free buffer with pH 4.7. The exposure to the
peptide free buffer arrested the swelling of the vesicle
and its projection length in the holding pipette ap-
proached a steady state. (The slow decrease of the
projection length after the beginning of washing was
due to peptide desorption.
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ever, this geometry is expected to be complex due to the
almost perpendicular orientation of the peptide relative to
the membrane normal (Zhou et al., 2000). The insertion of
the similar helical peptide maganin 2 in phophatidylcholine
membranes (Ludtke et al., 1995) showed that peptide inser-
tion was coupled with decreasing the membrane thinning.
Then, if the membrane thickness decreases with the inser-
tion of AcE4K, the mismatch at the boundary of the inserted
peptide will be similar to the initial stage of pore formation.
Then, if the mismatch is significant, we expect to observe a
significant decrease of the membrane tensile strength in the
presence of inserted peptide. The measurement of the mem-
brane tensile strength in the presence and the absence of
AcE4K (see Effect of AcE4K binding on the properties of
SOPC membranes in the Results section), showed that there
was no significant decrease of the membrane strength in the
presence of peptide. Similar results were obtained for the
wild-type wt-20 peptide by Longo et al. (1998). In the same
paper, the authors showed that the modification of wt-20 by
attaching fluorescein to its N terminus resulted in making a
modified peptide, which both substantially decreased the
membrane strength and compromised the ability of the
membrane to retain solutes. These data taken together sug-
gest that the insertion of AcE4K in the SOPC membrane
does not significantly change the equilibrium free energy of
the membrane.
The exchange of the AcE4K with the membrane results in
change of the number of molecules in the membrane. For
example, the insertion of each peptide molecule in the
membrane requires the creation of a vacancy for the peptide
molecule to fit between the membrane lipids. The creation
of the vacancy requires work and is coupled with a com-
pression of the outside membrane monolayer and an exten-
sion of the inside membrane monolayer. The stress between
the two membrane monolayers will be eventually relaxed.
However, the time of relaxation could be much longer than
the time of peptide insertion. Therefore, the work for cre-
ating a vacancy can be considered a temporary loss of free
energy of binding for the inserted molecule and should be
considered when measuring the rate of peptide adsorption
and desorption. The exchange of AcE4K with the mem-
brane occurs within several minutes (Figs. 6, 8 A, and 9).
This corresponds to desorption rates on the order of 0.13
s1, which is similar to the rate of desorption of the lyso-
lipid MOPC from SOPC membranes (Needham and Zhelev,
1995). Because AcE4K does not form large pores in the
membrane, one can anticipate rates of forced lipid transfer
across the membrane (or forced flip flop, Fattal et al., 1994),
on the order of 0.003 s1 (Needham and Zhelev, 1995).
Thus, both the adsorption of the peptide to the membrane
and its desorption will involve predominantly the peptide
inserted in the outside membrane monolayer. The work of
creating a vacancy in the outside membrane monolayer
during peptide adsorption is calculated from the product of
the monolayer tension and the area of the vacancy. These
two characteristics could be determined from the micropi-
pette measurements of the area expansion modulus of the
membrane in absence of peptide and the measured vesicle
area changes during peptide desorption.
In the experiments of peptide desorption, the vesicle was
incubated in the peptide solution for about 10 min and then
the adsorbed peptide was desorbed by flowing peptide-free
solution over the vesicle (Fig. 6). The characteristic time of
desorption was on the order of 5 min, however the half time
of desorption was on the order of 5 to 15 s (Fig. 8 A). In
these conditions, the peptide partitioned mainly in the out-
side vesicle monolayer. Then the work for the insertion of
one mole of peptide Wv0 was calculated by (Zhelev, 1998)
Wv0 K
Ap2
Alp
Na, (9)
where K was the area expansion modulus, Ap was the area
occupied by a single peptide molecule, Alp was the initial
area occupied by the lipids associated with the inserted
peptide, and Na was the Avogadro number.
The area Alp was found from the peptide concentration in
the membrane Cpm (on molar ratio basis), when 10 M
peptide was present in the solution. The peptide concentra-
tion Cpm, corresponding to the partition coefficient Kp, was
calculated from Cpm  KpCps, where Cps was the bulk
peptide concentration. The partition coefficient for pH 5.5
was 4.8  104, then the calculated peptide concentration in
the membrane was Cpm 8.63 103. The number of lipid
molecules per one bound peptide at pH 5.5 was 116. The
lipid molecules associated with a single peptide molecule
were present in the two membrane monolayers, then the
number of associated lipid molecules in one of the mem-
brane monolayers was 58. The area of a single SOPC
molecule was on the order of 65 Å2 (McIntosh and Simon,
1986). Then 58 lipids had an area of 3770 Å2. The measured
6% vesicle area change during peptide desorption corre-
sponded to an area per peptide molecule Ap on the order of
226 Å2. This value for the area per peptide molecule was
similar to the area of 120 Å2 or more occupied by the
mutant E4 in phosphatidylcholine monalyers at surface
pressure equal to the apparent bilayer pressure (Rafalski et
al, 1991). Ishiguro et al. (1996), considered the volume
occupied by the wild-type HA2 peptide, assuming that the
peptide was almost parallel to the membrane interface, and
estimated its area to be on the order of 300 Å2. This area
was also similar to the measured area of AcE4K. The area
expansion modulus K of the SOPC membrane, was chosen
equal to 190 (mN/m) (Needham and Nunn, 1990; Zhelev,
1998). Then the work for insertion of one mole of peptide in
the membrane was 15.5 kJ/mol (3.7 kcal/mol).
The mean field approximation used here allowed an
estimate of the apparent interfacial tension of the bound
peptide. The contact area between the peptide and the mem-
brane had an apparent interfacial tension. This apparent
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interfacial tension of the peptide contact area was calculated
from the ratio of the Gibbs energy for peptide transfer to the
area occupied by the inserted peptide. The calculated ap-
parent interfacial tension was on the order of 20 mN/m. This
value was somewhat smaller than the value of the apparent
interfacial tension for the membrane hydrocarbon region on
the order of 33 mM/m (Zhelev, 1998). The calculation of
the latter apparent interfacial tension was based on the
measured activation energy for transfer of a single hydro-
carbon to water, which was on the order of 0.68 kcal/mol
(Israelashvili, 1991). Another interfacial tension for com-
parison would be the alkane–water interfacial tension, equal
to 50 mN/m (Small, 1986), which represented the maximum
possible hydrocarbon–water interfacial tension. The com-
parison of the above interfacial tensions suggests that the
gain in free energy due to the removal of the hydrophobic
amino acid side chains from their water environment is a
major driving force for the binding of AcE4K to the mem-
brane.
The dominant role of the hydrophobic interactions for the
binding of AcE4K was also suggested by the correlation
between peptide binding and amino acid protonation. The
presented experimental data showed that the partitioning of
AcE4K increased with the decrease of the solution’s pH.
The partitioning was minimum for pH 7 and maximum for
pH 4.5. The measured partition coefficients were 3.1  102
for pH 7 and 3.2  106 for pH 4.5 (Fig. 4 A). The corre-
sponding Gibbs energies were 14.1 kJ/mol (3.4 kcal/mol)
and 37.1 kJ/mol (8.9 kcal/mol), respectively. Thus, the
apparent change of the Gibbs energy due to the protonation
of AcE4K from pH 7 to 4.5, was 23 kJ/mol (5.5 kcal/mol).
The amino acids expected to be protonated were the three
glutamatic acids and the aspartic acid, with pK of 4.7. The
Gibbs energies for transfer of these amino acids from water
to the phosphatidylcholine membrane were measured by
Wimley and White (1996) and were2.02 kcal/mol for Glu
and 1.23 kcal/mol for Asp at pH 8, and 0.01 kcal/mol for
Glu and 0.07 kcal/mol for Asp at pH 2. Thus, there was a
difference of 7.4 kcal/mol of the change of the Gibbs
energy, when the three glutamatic acids and the aspartic
acid were transferred to the membrane at pH 8 and pH 2,
respectively. This change of the Gibbs energy was very
close to measured change of the Gibbs energy on the order
of 5.5 kcal/mol for the binding of AcE4K at pH 7.5 and
4.5, respectively. The similarity of the change of the two
Gibbs energies suggested that the binding of AcE4K to the
SOPC membrane was directly related to the protonation of
the glutamatic acids and the acpartic acid.
The observation that the depth of insertion of AcE4K in
the membrane was independent of pH was consistent with
the similar finding for the wild-type HA2 fusion peptide
(Luneberg et al., 1995; Zhou et al., 2000). The indepen-
dence of the depth of insertion on pH suggested that the
membrane provided an interface for the folding of the
peptide, while the amount of adsorbed peptide at steady
state was dependent on the peptide’s bulk concentration and
the pH. In this regard, it was instructional to compare the
blue shift of the tryptophan fluorescence and the CD spectra
of the soluble AcE4K measured in this work and the same
characteristics for the Lipo-AcE4K (Bailey et al. 1997). The
maximum tryptophan fluorescence of the soluble AcE4K at
pH 7.5 was measured at 355 nm, whereas the maximum
fluorescence for Lipo-AcE4K at the same pH was measured
at 340 nm (Bailey et al. 1997). This apparent blue shift of
the maximum fluorescence for the lipid-linked peptide rel-
ative to the fluorescence for the soluble peptide suggested
that the lipid-linked peptide was in more hydrophobic en-
vironment compared to the soluble peptide. Compared to
pH 7.5, the maximum tryptophan fluorescence for pH 5 had
a blue shift of 14 nm (Fig. 1), whereas that for the Lipo-
AcE4K had a blue shift of 12 nm. These results showed that
the blue shift of both peptides was similar. However, the
lipid-linked peptide was partially inserted in the membrane
at neutral pH. In contrast, the dependence of peptide helicity
on pH was different for the two peptides. The helicity of the
soluble peptide was dependent on pH. For pH 7.5, there
were almost no -helical structures, but for pH 5 almost half
of the peptide was in -helical conformation (Fig. 2 B). In
contrast, the conformation of the lipid-linked peptide was
always -helical and independent of pH (Bailey et al.,
1997). The measured CD spectra for the Lipo-AcE4K
(Bailey et al., 1997) resembled with high accuracy the CD
spectra measured at pH 4.5 for the soluble peptide (Fig.
2 A). This comparison of the two peptides showed that the
lipid-anchored peptide was folded in its own membrane.
The additional blue shift at low pH of the Lipo-AcE4K and
its ability to assist the trafficking of lipid between mem-
branes (Bailey et al., 1997), suggested that, for low pH, the
Gibbs energy of binding to the opposing membrane was
lower than the energy of binding to the same membrane.
The conclusion that the increase of the measured helicity of
the soluble peptide was a result of an increase of the number
of inserted molecules while the depth of insertion was the
same, and the finding that the CD spectra of the Lipo-
AcE4K resemble the spectra for maximum binding of
AcE4K, suggested that the peptide from the lipo-peptide
was always inserted in the membrane. Thus, the linkage of
the peptide to the lipid lowered the energy of peptide
insertion in the membrane.
The insertion of the peptide in the membrane also af-
fected the membrane mechanical properties. The ability of
the inserted peptide to disturb the membrane structure and
compromise the membrane stability was dependent on pH.
Below the threshold pH of 4.8, the inserted peptide created
membrane pores, which led to membrane breakdown. The
pores formed by the adsorbed peptide were reversible,
which showed that the binding of the peptide in the pore
region was reversible. The formation of membrane pores
alone did not lead to membrane fusion. We performed a test
for membrane fusion by holding two in contact while ex-
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posing them to peptide solution at pH 4.7. In all measure-
ments, the membranes broke down and no fusion events
were observed. The absence of fusion events suggested that
the species promoting defect formation were inserted into
the membrane and could not provide the necessary bridging
between the membranes in the contact region. This was
consistent with the similar finding for the other HA2 fusion
peptide mutants, which also were not able to fuse large
unilamellar vesicles (Wilshut and Bron, 1993).
CONCLUSION
In conclusion, we showed that the HA2 fusion peptide
mutant AcE4K inserts in the membrane of SOPC vesicles in
a pH-dependent manner. For pH above 5, this insertion did
not significantly affect the stability (tensile strength or pore
formation) of the membrane, but below pH 4.85, the stabil-
ity of the membrane was significantly compromised. The
inserted peptide resigned close to the membrane interface,
which was demonstrated by fluorescence quenching. The
inserted peptide occupied an area in the membrane on the
order of 200 Å2 per peptide molecule. This area led to a
significant increase of the total membrane area after peptide
adsorption. The adsorption of the peptide was characterized
by the change of the Gibbs energy of binding. The Gibbs
energy of binding increased with the decrease of the pH and
was maximum for pH 4.5. With the decrease of the pH, the
number of the bound molecules increased, but the depth of
insertion of the individual molecules in the membrane was
independent of pH. This finding allowed us to use a simple
model for the binding of AcE4K, where the binding of each
peptide was coupled with doing work for creating a vacancy
for the peptide molecule in the membrane. The calculation
of this work for creating a vacancy for pH 5.5 showed that
the work for creating a vacancy was an important determi-
nant of the rate of peptide binding. Our data suggested that
the binding of the peptide to the membrane was driven by
hydrophobic interactions. The pH dependence of the pep-
tide binding was due to peptide protonation and an apparent
increase of the peptide hydrophobicity.
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